DoW Kidney Cancer, Idea Development Award

August 26, 2026 0

Due: September 28, 2026 The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to Read More

DoW Alzheimer’s Transforming Care Award

August 26, 2026 0

Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for Read More

DoW Alzheimer’s Transforming Diagnosis Award

August 26, 2026 0

Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and Read More

DoW Alzheimer’s Transforming Research Award

August 26, 2026 0

Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s Read More

DoW Neurofibromatosis Exploration-Hypothesis Development Award

August 18, 2026 0

Due: September 22, 2026 The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported Read More

DoW Neurofibromatosis Research Academy Scholar Award

August 18, 2026 0

Due: September 22, 2026 The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy’s Scholar Award (NFRA-SA) supports early-career independent investigators (Scholars) joining the Neurofibromatosis Research Academy to pursue a neurofibromatosis project that Read More

1 2 3 5